Oragenics, Inc. (OGEN)
Develops nasal spray treatments for brain injuries and infections.
$0.50-0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-60.2%
The outlook
OGEN is trading near its 52-week low at $0.497, well below both its 50- and 200-day moving averages. Analyst coverage appears limited or absent. The current market positioning shows minimal upside room within its recent range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$2.2M
52-wk high
$1.45
52-wk low
$0.49
50-day avg
$0.58
200-day avg
$0.79
Trailing P/E
—